Subject: Low levels of vitamin D and worsening of knee osteoarthritis: Results of two longitudinal studies



Home / Medical, Veterinary and Health Sciences / Rheumatology





Arthritis & Rheumatism

  What is RSS?

Volume 56, Issue 1 , Pages 129 - 136

Published Online: 28 Dec 2006

Copyright © 2006 by the American College of Rheumatology



Published on behalf of
Go to Society Site

< Previous Abstract  |  Next Abstract >

  Save Article to My Profile        Download Citation

Abstract  |  References  |  Full Text: HTML, PDF (80k)  |  Related Articles  |  Citation Tracking



 Research Article

Low levels of vitamin D and worsening of knee osteoarthritis: Results of two longitudinal studies

David T. Felson 1 *, Jingbo Niu 1, Margaret Clancy 1, Piran Aliabadi 2, Burton Sack 1, Ali Guermazi 1, David J. Hunter 1, Shreyasee Amin 3, Gail Rogers 4, Sarah L. Booth 4

1Boston University School of Medicine, Boston, Massachusetts

2Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts

3Mayo Clinic College of Medicine, Rochester, Minnesota

4Tufts University, Boston, Massachusetts

email: David T. Felson (

*Correspondence to David T. Felson, Boston University School of Medicine, 715 Albany Street, Suite A203, Boston, MA 02118

Funded by:
  National Heart, Lung, and Blood Institute's Framingham Heart Study; Grant Number: N01-HC-25195
  Osteoarthritis Biomarkers grant from the Arthritis Foundation
  NIH; Grant Number: AR-47785, AG-18393, AG-14759
  USDA; Grant Number: 58-1950-4-401



To confirm reports that 25-hydroxyvitamin D (25[OH]D) deficiency is associated with an increased risk of joint space narrowing or cartilage loss in osteoarthritis (OA).


We measured 25(OH)D levels in subjects from 2 longitudinal cohort studies, the Framingham Osteoarthritis Study and the Boston Osteoarthritis of the Knee Study (BOKS). In the first, weight-bearing anteroposterior (AP) and lateral knee radiographs were obtained on subjects in 1993-1994 and again in 2002-2005 (mean interval 9 years); blood was drawn for measurement of vitamin D status in 1996-2000. In the second, subjects with symptomatic knee OA participating in a natural history study had fluoroscopically positioned semiflexed posteroanterior (PA) and lateral radiography of both knees and magnetic resonance imaging (MRI) of the more symptomatic knee performed at baseline and at 15 and 30 months. Blood was drawn at all visits, and the baseline specimen was used when available. In both studies, we defined radiographic worsening based on joint space loss in the tibiofemoral joint on either AP/PA or lateral weight-bearing views, using a semiquantitative scale (worsening defined as increase by  1 on a 0-3 scale). In the BOKS, we evaluated cartilage loss semiquantitatively, using the Whole-Organ Magnetic Resonance Imaging Score. In both studies, 25(OH)D levels were measured by radioimmunoassay. Analyses focused on whether vitamin D levels, defined in tertiles or as deficient (25[OH]D <20 ng/ml) versus nondeficient, predicted worsening of OA. Logistic regression analysis adjusted for age, body mass index, sex, and baseline OA level was used.


The 715 subjects in the Framingham Study had a mean 25(OH)D level of 20 ng/ml at baseline, and 20.3% of the knees showed worsening, during the course of the study, with most knees having had no evidence of OA at baseline. The 277 subjects with OA in the BOKS had a mean 25(OH)D level of 20 ng/ml at baseline with 23.6% of knees showing radiographic worsening. We found no association of baseline 25(OH)D levels with radiographic worsening in either cohort, and confidence limits in the analyses of vitamin D deficiency were narrow, suggesting that results were not based on insufficient power. In fact, the risk of worsening was slightly, but not significantly, lower in persons with low levels of vitamin D than in persons with higher levels. In the BOKS, vitamin D levels were unrelated to cartilage loss seen on MRI.


The findings indicate that vitamin D status is unrelated to the risk of joint space or cartilage loss in knee OA.

Received: 30 June 2006; Accepted: 19 September 2006

Digital Object Identifier (DOI)

10.1002/art.22292  About DOI



Related Articles

  • Find other articles like this in Wiley InterScience
  • Find articles in Wiley InterScience written by any of the authors

Wiley InterScience is a member of CrossRef.



All Content

Publication Titles

Enter words or phrases



Arthritis & Rheumatism

Enter words or phrases

Select a Field

All Fields

Article Titles


Full Text / Abstracts

Author Affiliation


Funding Agency


Article DOI












Get select content from some of Wiley's leading publications delivered to your PDA — free!

Sign up now




Need a reprint?

Paper or electronic reprints are available for all content published on Wiley InterScience. Inquiries can be submitted online.

Find out more about reprints



General Medicine


Fully searchable and live-linked with current web content, this backfile brings the complete contents of 20 leading journals, 62,500 articles, to your desktop. A one-time fee delivers ongoing access.

Find out more
Request a Quote



all-the-time answers
at the point of care.

Subscribe Today!



Backfiles on Pay-Per-View


More than 600,000 journal articles starting at Volume 1, Issue 1, dating as far back as 1800s and spanning the disciplines of chemistry, life sciences, medicine and materials science are now available online for Pay-Per-View purchase on Wiley InterScience.

Browse Journals by Subject




EBM Guidelines

(Evidence-Based Medicine)

The key source of practical information for primary care with the most extensive collection of concise treatment recommendations




Musculoskeletal Care journals

Wiley publishes a full range of Musculoskeletal Care journals



About Wiley InterScience  |  About Wiley  |  Privacy  |  Terms & Conditions
© 1999-2008 John Wiley & Sons, Inc. All Rights Reserved.